ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,413Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 682

$1.97M Total Retail Price of All Prescriptions

Rank: 11 out of 682

480 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 21,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
METOPROLOL TARTRATE 912 674 1 10
LISINOPRIL 864 650 2 2
LEVOTHYROXINE SODIUM 857 644 3 3
SIMVASTATIN 845 659 4 4
DONEPEZIL HCL 717 685 5 30
POTASSIUM CHLORIDE 690 580 6 14
WARFARIN SODIUM 685 622 7 13
AMLODIPINE BESYLATE 673 553 8 6
NAMENDA 668 618 9 41
FUROSEMIDE 560 445 10 7
DIVALPROEX SODIUM 557 434 11 84
HYDROCODONE-ACETAMINOPHEN 546 409 S3 12 1
MIRTAZAPINE 485 424 13 52
METFORMIN HCL 462 283 14 8
OMEPRAZOLE 455 343 15 5
SERTRALINE HCL 417 300 16 24
ENOXAPARIN SODIUM 401 355 10 17 215
LEVETIRACETAM 397 291 18 125
RISPERIDONE 372 241 19 82
LANTUS 354 230 20 55
CITALOPRAM HBR 348 261 21 17
CARVEDILOL 330 254 22 23
TRAZODONE HCL 312 244 23 38
ATORVASTATIN CALCIUM 295 227 24 11
ALLOPURINOL 279 224 25 32
GABAPENTIN 275 178 26 9
PANTOPRAZOLE SODIUM 249 169 27 29
HYDRALAZINE HCL 241 186 28 74
EXELON 218 208 29 104
NOVOLOG 195 170 30 129
CRESTOR 193 125 31 22
TAMSULOSIN HCL 193 153 31 33
ADVAIR DISKUS 192 135 33 47
ALENDRONATE SODIUM 188 155 34 37
OLANZAPINE 184 139 35 168
HYDROCHLOROTHIAZIDE 184 159 35 12
POLYETHYLENE GLYCOL 3350 176 131 37 44
KLOR-CON M20 175 139 38 67
GLIPIZIDE ER 175 127 38 108
ISOSORBIDE MONONITRATE ER 173 157 40 31
LACTULOSE 169 134 41 100
NOVOLIN R 168 112 42 167
LEVOFLOXACIN 161 140 43 70
PLAVIX 155 130 44 35
FAMOTIDINE 153 148 45 99
CLOPIDOGREL 151 114 46 25
RANITIDINE HCL 149 76 47 28
JANUVIA 140 92 48 62
BUMETANIDE 133 110 49 115
MUPIROCIN 133 85 49 166
FENTANYL 128 118 S2 51 86
FLUOXETINE HCL 126 85 52 60
GLIPIZIDE 124 105 53 61
QUETIAPINE FUMARATE 123 100 54 87
METOPROLOL SUCCINATE 123 121 54 16
SPIRONOLACTONE 118 55 56 64
LOSARTAN POTASSIUM 115 77 57 20
NYSTATIN 114 82 58 95
JANTOVEN 113 89 59 208
SPIRIVA 112 66 60 49
ZOLPIDEM TARTRATE 112 53 60 21
CYMBALTA 108 31 62 51
TRAMADOL HCL 107 74 63 26
LIDODERM 103 103 64 134
METOCLOPRAMIDE HCL 103 65 64 111
DIGOXIN 102 97 66 46
ZETIA 101 90 67 69
CLONIDINE HCL 101 56 67 48
FLUTICASONE PROPIONATE 100 81 69 36
CEPHALEXIN 98 85 70 128
OXYBUTYNIN CHLORIDE ER 96 84 71 180
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 69 72 103
DIOVAN 93 60 73 42
SEROQUEL 91 60 74 193
RAMIPRIL 91 82 74 81
IPRATROPIUM-ALBUTEROL 91 74 74 139
ESCITALOPRAM OXALATE 90 73 77 73
PROMETHAZINE HCL 88 52 R 78 54
BACLOFEN 86 47 79 130
SPS 82 77 80 399
GENERLAC 81 70 81 270
FENOFIBRATE 81 51 81 76
VENLAFAXINE HCL ER 79 71 83 119
PREVACID 79 43 83 402
PREDNISONE 78 61 85 40
LEXAPRO 77 32 86 222
ABILIFY 76 50 87 179
AMOX TR-POTASSIUM CLAVULANATE 75 57 88 110
LAMOTRIGINE 70 42 89 210
BENZTROPINE MESYLATE 70 34 R 89 197
ALBUTEROL SULFATE 70 62 89 156
FLUCONAZOLE 69 53 92 154
CLINDAMYCIN HCL 68 54 93 307
TRAVATAN Z 67 52 94 303
PROAIR HFA 66 36 95 45
GEMFIBROZIL 65 65 96 122
BUSPIRONE HCL 65 58 96 102
LIPITOR 64 48 98 92
OXYCODONE HCL-ACETAMINOPHEN 64 25 S2 98 98
ZYPREXA 63 47 100 368
LYRICA 62 58 101 78
FONDAPARINUX SODIUM 62 11 101 434
ISOSORBIDE DINITRATE 62 52 101 246
VENTOLIN HFA 62 38 101 101
PHENYTOIN SODIUM EXTENDED 61 30 105 140
LOVASTATIN 61 44 105 66
INSULIN SYRINGE 61 34 105 75
HUMALOG 60 44 108 213
DOXAZOSIN MESYLATE 60 49 108 96
FINASTERIDE 59 46 110 131
SENSIPAR 58 15 111 287
NOVOLIN 70-30 58 22 111 189
NEXIUM 58 40 111 19
SINGULAIR 54 35 114 63
NIASPAN 53 28 115 133
METRONIDAZOLE 53 49 115 254
BUPROPION XL 53 22 115 207
ATENOLOL 52 42 118 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.